[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355296-105":59,"doc-detail-355296-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-papillomavirus-encoded-micrornas-key-regulators-in-cervical-cancer-development","Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development","","Human papillomaviruses (HPVs) drive diverse cutaneous and mucosal diseases, and multiple genotypes are strongly linked to cervical cancer. Beyond host microRNAs, HPV encodes viral microRNAs (v-miRNAs) that regulate both viral and host gene expression, shaping oncogenic pathways such as cell-cycle control, apoptosis, immune evasion, and epithelial–mesenchymal transition. These regulatory networks promote viral persistence and malignant transformation. v-miRNA stability and specificity support biomarker potential for cervical cancer diagnosis and prognosis, though clinical adoption remains difficult. This review consolidates validated molecular targets and emerging therapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-papillomavirus-encoded-micrornas-key-regulators-in-cervical-cancer-development/355296/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-papillomavirus-encoded-micrornas-key-regulators-in-cervical-cancer-development/355296.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do HPV-encoded microRNAs (v-miRNAs) play in cervical cancer development?","Question",{"text":112,"@type":113},"HPV encodes v-miRNAs that modulate both viral and host gene expression. They influence oncogenic pathways including cell-cycle control, apoptosis, immune evasion, and epithelial–mesenchymal transition, promoting viral persistence and malignant transformation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are HPV genotypes associated with cancer risk described in the document?",{"text":117,"@type":113},"The text distinguishes low-risk types (e.g., HPV 6 and 11) associated with benign lesions from high-risk types (notably HPV 16 and 18) closely linked to cervical intraepithelial neoplasia and cervical cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are v-miRNAs considered promising biomarkers for cervical cancer?",{"text":121,"@type":113},"The review notes that v-miRNAs have stability and specificity, which can support biomarker use for diagnosis and prognosis. However, translating this into clinical practice is described as challenging.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355296,1790175423,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development  \nSanae Bencheikha,b, Hajar Lemriss c, Amal Souiri b, Jihane Akachard, Khalid Laarejb, Rabii Ameziane El Hassani a and Sanaâ Lemriss b  \naLaboratory of Biology of Human Pathologies (BioPatH), Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco; bDepartment of Biosafety (PCL3), Laboratory for Research and Medical Analysis, Royal Gendarmerie, Royal Gendarmerie School, Rabat, Morocco; cLaboratory of Biomedical Sciences and Engineering, Biophysics and HealthHigher Institute of Health Sciences, Hassan I University of Settat, Settat, Morocco; dBRET LAB, Mohammed VI University of Health and Sciences, Casablanca, Morocco  \nABSTRACT  \nHuman papillomaviruses (HPVs) cause diverse cutaneous and mucosal diseases, with several genotypes strongly associated with cervical cancer. Beyond the well-established role of cellular microRNAs (miRNAs) in gene regulation, increasing evidence shows that HPV also encodes its own viral miRNAs (v-miRNAs). These v-miRNAs modulate both viral and host gene expression, influencing key pathways involved in oncogenesis, including cell cycle control, apoptosis, immune evasion, and epithelial – mesenchymal transition. By shaping these regulatory networks, HPV-derived miRNAs promote viral persistence and contribute to malignant transformation. Their stability and specificity also make them promising biomarkers for cervical cancer diagnosis and prognosis, although clinical translation remains challenging. This review provides an updated overview of HPV-encoded miRNAs, their validated molecular targets, and their roles in tumour development. It also highlights emerging therapeutic strategies and future perspectives for integrating miRNAbased approaches into precision oncology for HPV-related cervical cancer.  \nARTICLE HISTORY  \nRevised 11 February 2026 Accepted 2 March 2026  \nKEYWORDS  \nHPV; HPV-encoded microRNAs; viral microRNAs; cervical cancer; oncogenesis; biomarkers  \nIntroduction  \nCervical cancer remains a major public health concern, particularly among women in developing countries, where healthcare infrastructure often lags behind. After lung, colorectal, and breast cancers, cervical cancer ranks fourth among cancers in women worldwide [ 1]. Approximately 600.000 new cases are estimated to be diagnosed annually, resulting in 340.000 deaths worldwide [ 1]. In countries with advanced healthcare systems, cervical cancer mortality has decreased significantly, mostly because to efficient screening and vaccination programmes. Nevertheless, its incidence remains distressingly high in many developing countries [2].  \nIn Morocco, Cervical cancer is the second most common cancer among women. The age-standardized incidence rate (ASR) is estimated at 15 per 100,000 women in Casablanca and 13 per 100,000 in Rabat figures that is markedly high compared to other North African nations like Egypt, where the ASR is only 2.3 per 100,000 women [3].  \nThe causal link between high-risk human papillomavirus (HR-HPV) infection and cervical cancer has been well-established through various epidemiological and functional studies [4].  \nHPV and virus-encoded miRnas  \nGenomic characterization of HPV  \nHPVs are non-enveloped, double-stranded DNA (dsDNA) viruses that belong to the Papillomaviridae family [ 5,6 ] . Human papillomavirus (HPV) is the most prevalent oncogenic virus associated with infection-related carcinogenesis [7 ], with its highest prevalence occurring in  \nCONTACT Sanaâ Lemriss  [slemriss@lram-fgr.ma](slemriss@lram-fgr.ma)  Department of Biosafety (PCL3), Laboratory for Research and Medical Analysis, Royal Gendarmerie, Royal Gendarmerie School, Rabat 10100, Morocco  \n© 2026 The Author(s) . Published by Informa UK Limited, trading as Taylor & Francis Group.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([http://creativecommons.org/licenses/by-nc/4](h","cbCaisiXRhNILrZR","https://ap.wps.com/l/cbCaisiXRhNILrZR","pdf",2220133,14,"English","# Introduction\n## Cervical cancer public health burden\n## HPV and viral microRNAs (v-miRNAs)\n# HPV and virus-encoded miRnas\n## Genomic characterization of HPV\n## Oncogenic potential: low-risk vs high-risk types\n## HPV entry and early infection processes","[{\"question\":\"What role do HPV-encoded microRNAs (v-miRNAs) play in cervical cancer development?\",\"answer\":\"HPV encodes v-miRNAs that modulate both viral and host gene expression. They influence oncogenic pathways including cell-cycle control, apoptosis, immune evasion, and epithelial–mesenchymal transition, promoting viral persistence and malignant transformation.\"},{\"question\":\"How are HPV genotypes associated with cancer risk described in the document?\",\"answer\":\"The text distinguishes low-risk types (e.g., HPV 6 and 11) associated with benign lesions from high-risk types (notably HPV 16 and 18) closely linked to cervical intraepithelial neoplasia and cervical cancer.\"},{\"question\":\"Why are v-miRNAs considered promising biomarkers for cervical cancer?\",\"answer\":\"The review notes that v-miRNAs have stability and specificity, which can support biomarker use for diagnosis and prognosis. However, translating this into clinical practice is described as challenging.\"}]","Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development | PDF",1790117458,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b0215cc9865e61e49b04bbb9fc393a5.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56cd2ad0945e29367c62b47e735d9154.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f07183203d768c089ad02a9a416a769.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64d825608d8addce7c946307cb5036f4.webp",980,1306]